SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014474
Filing Date
2022-08-04
Accepted
2022-08-04 07:25:49
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20220630.htm   iXBRL 10-Q 2784924
2 EX-31.1 dyn-ex31_1.htm EX-31.1 14760
3 EX-31.2 dyn-ex31_2.htm EX-31.2 15819
4 EX-32.1 dyn-ex32_1.htm EX-32.1 7549
5 EX-32.2 dyn-ex32_2.htm EX-32.2 7439
  Complete submission text file 0000950170-22-014474.txt   7645291

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220630_lab.xml EX-101.LAB 392514
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220630.xsd EX-101.SCH 46383
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyn-20220630_cal.xml EX-101.CAL 48223
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyn-20220630_def.xml EX-101.DEF 123960
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220630_pre.xml EX-101.PRE 291744
52 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220630_htm.xml XML 1201000
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 221134685
SIC: 2834 Pharmaceutical Preparations